MALT1 mutations impair normal NF-κB activation and paracaspase activity to cause a novel combined immunodeficiency. The clinical and immunological phenotype of MALT1 deficiency can be successfully treated with hematopoietic stem cell transplantation following reduced intensity conditioning.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.clim.2016.04.011 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!